BREAKING
Nucor Jumps 5.5% After UBS Downgrades to Neutral 1 hour ago LGI Homes Edges Past Q1 2026 Estimates, Posts $0.24 EPS, Revenue Down 9% 2 hours ago Molina Healthcare Jumps 5.7% After Wells Fargo Maintains Equal-Weight 2 hours ago COPT Defense Properties Crushes Q1 2026 Profit Estimates 2 hours ago Cincinnati Financial Delivers 12% Revenue Growth in Q1 2026 3 hours ago Armstrong World Industries Falls Short of Q1 2026 Profit Forecast at $1.69 EPS 3 hours ago Franklin Resources Releases Q2 2026 Financial Results 3 hours ago JetBlue Airways Reports 20.8% Wider Q1 2026 Loss at -$0.87/Share 3 hours ago NexPoint Residential Trust Q1 2026 EPS Tops Expectations 3 hours ago Down 19.6%: Purple Innovation Slides After Q1 2026 Widening Loss 3 hours ago Nucor Jumps 5.5% After UBS Downgrades to Neutral 1 hour ago LGI Homes Edges Past Q1 2026 Estimates, Posts $0.24 EPS, Revenue Down 9% 2 hours ago Molina Healthcare Jumps 5.7% After Wells Fargo Maintains Equal-Weight 2 hours ago COPT Defense Properties Crushes Q1 2026 Profit Estimates 2 hours ago Cincinnati Financial Delivers 12% Revenue Growth in Q1 2026 3 hours ago Armstrong World Industries Falls Short of Q1 2026 Profit Forecast at $1.69 EPS 3 hours ago Franklin Resources Releases Q2 2026 Financial Results 3 hours ago JetBlue Airways Reports 20.8% Wider Q1 2026 Loss at -$0.87/Share 3 hours ago NexPoint Residential Trust Q1 2026 EPS Tops Expectations 3 hours ago Down 19.6%: Purple Innovation Slides After Q1 2026 Widening Loss 3 hours ago
ADVERTISEMENT
INCY

Incyte Corporation

$INCY NASDAQ Apr 28, 2026 All Day FY 2026

Investor Toolbox

Listen to Call

Recording not yet available.

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

INCY Coverage

Transcript Incyte Corporation (INCY) Q1 2026 Earnings Call Transcript Apr 28, 2026 News Incyte Q1 2026 EPS Tops Expectations by 29.3%, Revenue Up 21% Apr 28, 2026 News Incyte Releases Q1 2026 Financial Results Apr 28, 2026 Event Incyte Corporation (INCY) Q1 2026 Earnings Results Apr 28, 2026 Event Incyte Corporation (INCY) Incyte Highlights New Phase 3 Tafasitamab Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Apr 21, 2026 Event Incyte Corporation (INCY) Q1 2026 Earnings Call Apr 9, 2026 Transcript Incyte Corporation (INCY) Q4 2025 Earnings Call Transcript Mar 10, 2026 News Incyte Corporation Reports Strong 2025 Fiscal Results and Provides 2026 Guidance Feb 10, 2026